Page last updated: 2024-12-10

sulfenamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

sulfenamide: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5311466
MeSH IDM0446066

Synonyms (5)

Synonym
sulfenamide
5,13-dimethoxy-4,6-dimethyl-9-thia-10,17-diaza-2-azoniatetracyclo[8.7.0.02,7.011,16]heptadeca-1(17),2(7),3,5,11(16),12,14-heptaene;chloride
121459-89-0
3,9-dimethoxy-2,4-dimethyl-5h-benzo[4,5]imidazo[1,2-b]pyrido[1,2-d][1,2,4]thiadiazin-13-ium chloride
3,9-dimethoxy-2,4-dimethyl-5h-benzo[4,5]imidazo[1,2-b]pyrido[1,2-d][1,2,4]thiadiazin-13-iumchloride

Research Excerpts

Effects

ExcerptReferenceRelevance
"Sulfenamides have been shown to revert to the parent drug via reaction with thiols."( In vitro conversion of model sulfenamide prodrugs in the presence of small molecule thiols.
Nti-Addae, KW; Stella, VJ, 2011
)
1.38

Bioavailability

ExcerptReferenceRelevance
" The enhanced oral absorption consequently promoted the bioavailability of metformin from 43% to 65% in rats."( The first bioreversible prodrug of metformin with improved lipophilicity and enhanced intestinal absorption.
Huttunen, KM; Järvinen, T; Kemppainen, E; Laine, K; Leppänen, J; Mannila, A; Rautio, J; Vepsäläinen, J, 2009
)
0.35

Dosage Studied

ExcerptRelevanceReference
"The objective of this Letter is to report the first (to our knowledge) in vivo proof of concept for a sulfenamide prodrug to orally deliver a poorly soluble drug containing a weakly-acidic NH-acid from a conventional solid dosage formulation."( An amide-based sulfenamide prodrug of gamma secretase inhibitor BMS-708163 delivers parent drug from an oral conventional solid dosage form in male beagle dog.
Clarke, W; Everlof, JG; Guarino, VR; Haskell, R; Lentz, KA; McDonald, I; Olson, RE; Wang, N, 2020
)
1.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (42)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (2.38)18.7374
1990's0 (0.00)18.2507
2000's13 (30.95)29.6817
2010's19 (45.24)24.3611
2020's9 (21.43)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.05 (24.57)
Research Supply Index3.78 (2.92)
Research Growth Index4.60 (4.65)
Search Engine Demand Index56.46 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (39.05)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other42 (97.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]